Portal de Periódicos da CAPES

Characterizing Out-of-Pocket Payments and Financial Assistance for Patients Prescribed Abiraterone and Enzalutamide at an Academic Cancer Center Specialty Pharmacy

2021; Lippincott Williams & Wilkins; Volume: 18; Issue: 2 Linguagem: Inglês

10.1200/op.21.00168

2688-1535

Angelina Jeong, Eric Schwartz, Andrea R. Roman, Rachel L McDevitt, Mary Oerline, E.E. Henry, Christine M. Veenstra, Megan E.V. Caram,

Pharmaceutical Economics and Policy

Abiraterone and enzalutamide are commonly used oral cancer therapies for patients with prostate cancer, both with potentially high out-of-pocket costs for patients. We investigated the prevalence of financial assistance mechanisms used to alleviate out-of-pocket costs and the association of these mechanisms with timing of treatment initiation of abiraterone or enzalutamide.